Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.51
-0.12 (-1.57%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aura Biosciences Employees
As of December 31, 2023, Aura Biosciences had 89 total employees, including 88 full-time and 1 part-time employees. The number of employees increased by 17 or 23.61% compared to the previous year.
Employees
89
Change (1Y)
17
Growth (1Y)
23.61%
Revenue / Employee
n/a
Profits / Employee
-$935,011
Market Cap
375.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 89 | 17 | 23.61% |
| Dec 31, 2022 | 72 | 20 | 38.46% |
| Dec 31, 2021 | 52 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
AURA News
- 2 months ago - Muscle Invasive Bladder Cancer Drug Pipeline Market Research 2024 Featuring Aura Biosciences, Janssen Research & Development, Asieris Pharmaceuticals, and RemeGen - GlobeNewsWire
- 4 months ago - Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value - Seeking Alpha
- 4 months ago - Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease - Benzinga
- 4 months ago - Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial - GlobeNewsWire
- 4 months ago - 3 Small-Cap Stocks Ready to Deliver Significant Growth - Benzinga
- 5 months ago - Sept. 13-20 Undercovered Stock Picks: Aura Biosciences, APA Corporation, iTeos, CuriosityStream + - Seeking Alpha
- 5 months ago - Aura Biosciences: Highly Derisked Late-Stage Eye Cancer Company - Seeking Alpha
- 5 months ago - Aura Biosciences Touts Promising Data From Eye Cancer Candidate - Benzinga